(Q37656300)

21 August 2017

1 reference

title

Sorafenib therapy for metastatic renal carcinoma in patients with low cardiac ejection fraction: report of two cases and literature review (English)

1 reference

21 August 2017

1 reference

1 reference

1 reference

Pratima Kamada

1

1 reference

PubMed ID

20014944

21 August 2017

Arkadiusz Z Dudek

series ordinal

2

1 reference

21 August 2017

1 June 2010

1 reference

21 August 2017

1 reference

21 August 2017

28

1 reference

21 August 2017

5

1 reference

21 August 2017

501-504

1 reference

Vascular complications of selected cancer therapies

21 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F07357900903476794

Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903476794

Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903476794

Heart failure associated with sunitinib malate: a multitargeted receptor tyrosine kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903476794

Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903476794

Cardiac toxicity of sunitinib and sorafenib in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903476794

Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903476794

Mechanisms of hypertension associated with BAY 43-9006.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903476794

Ambulatory monitoring detects sorafenib-induced blood pressure elevations on the first day of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903476794

Increased cardiotoxicity of sorafenib in sunitinib-pretreated patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903476794

Response to sorafenib after sunitinib-induced acute heart failure in a patient with metastatic renal cell carcinoma: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903476794

VEGF is critical for stem cell-mediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903476794

Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903476794

Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903476794

Mechanisms of myocyte cytotoxicity induced by the multiple receptor tyrosine kinase inhibitor sunitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903476794

Effect of the multitargeted tyrosine kinase inhibitors imatinib, dasatinib, sunitinib, and sorafenib on mitochondrial function in isolated rat heart mitochondria and H9c2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903476794

10.3109/07357900903476794

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

20014944